Advertisement
Screener

ATARA BIOTHERAPEUTICS, INC. (ATRA) Graph

ATRA Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2014-09-30: Research and development $2.00M.

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

ATRA revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Revenue$630.00KOperating income-$4.72MOther income, net$0.00Research & development$1.34MPre-tax income-$4.83MIncome tax$1.00KNet income-$4.83M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 1 month

Period endResearch and development
2014-09-30$2.00M

Revenue and expense 3 month

Period endRevenueRevenue including taxResearch and developmentOperating expensesIncome taxNet income
2026-06-30$630.00K(m)$1.34M(m)$1.00K-$4.83M
2026-03-31$516.00K(m)$164.00K(m)$0.00-$4.14M
2025-12-31$1.59M*(m)-$223.00K*(m)$0.00*-$3.41M*
2025-09-30$3.45M(m)$2.92M(m)$28.00K-$4.30M
2025-06-30$17.57M(m)$7.31M(m)$3.00K$2.39M
2025-03-31$98.15M(m)$27.43M(m)$0.00$38.01M
2024-09-30$40.19M$40.19M$43.92M(m)-$17.00K-$21.91M
2024-06-30$28.64M$28.64M$33.33M(m)$0.00-$19.05M
2024-03-31$27.36M$27.36M$45.51M(m)$24.00K-$31.75M
2023-09-30(m)$2.14M$56.89M(m)-$19.00K-$69.80M
2023-06-30(m)$957.00K$56.14M$72.37M$1.00K-$71.11M
2023-03-31(m)$1.23M$62.16M$76.24M$22.00K-$74.77M
2022-12-31(m)(m)(m)$75.76M*(m)(m)
2022-09-30(m)$4.46M$70.16M$89.08M$10.00K-$84.09M
2022-06-30(m)$51.58M$64.90M$83.71M$0.00$18.47M
2022-03-31(m)$7.31M$74.96M$95.53M$0.00-$88.11M
2021-09-30(m)(m)$70.33M$90.18M$0.00-$84.66M
2021-06-30(m)(m)$68.47M$87.87M$16.00K-$83.79M
2021-03-31(m)(m)$64.06M$81.80M$0.00-$78.33M
2020-09-30(m)(m)$59.88M$74.71M$6.00K-$74.35M
2020-06-30(m)(m)$61.56M$77.95M$1.00K-$77.46M
2020-03-31(m)(m)$57.66M$74.70M(m)-$73.51M
2019-09-30(m)(m)$53.54M$72.56M$0.00-$71.89M
2019-06-30(m)(m)$52.25M$75.53M$0.00-$74.33M
2019-03-31(m)(m)$48.67M$67.89M(m)-$66.26M
2018-09-30(m)(m)$43.35M$60.22M$0.00-$58.36M
2018-06-30(m)(m)$33.39M$52.62M$3.00K-$50.88M
2018-03-31(m)(m)$28.46M$42.45M$0.00-$41.44M
2017-09-30(m)(m)$20.60M$31.66M$0.00-$31.10M
2017-06-30(m)(m)$18.30M$27.91M$0.00-$27.43M
2017-03-31(m)(m)$17.54M$26.16M$2.00K-$25.65M
2016-09-30(m)(m)$18.80M$25.94M$7.00K-$25.37M
2016-06-30(m)(m)$12.99M$19.48M$0.00-$18.88M
2016-03-31(m)(m)$11.25M$17.06M$3.00K-$16.56M
2015-09-30(m)(m)$8.11M$12.26M-$11.00K-$11.87M
2015-06-30(m)(m)$11.51M$15.11M(m)-$14.95M
2015-03-31(m)(m)$5.77M$9.31M$2.00K-$9.16M
2014-09-30(m)(m)(m)$5.95M(m)-$5.92M
2014-06-30(m)(m)(m)$4.53M(m)-$4.51M
2014-03-31(m)(m)(m)$7.08M-$22.00K-$7.05M
2013-09-30(m)(m)(m)$2.55M-$13.00K-$2.54M

Revenue and expense 4 month

Period endOperating expensesIncome taxNet income
2012-12-31$4.09M$17.00K-$4.11M

Revenue and expense 6 month

Period endRevenueRevenue including taxResearch and developmentOperating expensesIncome taxNet income
2026-06-30$1.15M(m)$1.51M(m)$1.00K-$8.98M
2025-06-30$115.72M(m)$34.74M(m)$3.00K$40.40M
2024-06-30$56.00M$56.00M$78.84M(m)$24.00K-$50.80M
2023-06-30(m)$2.18M$118.30M$148.62M$23.00K-$145.88M
2022-06-30(m)$58.89M$139.86M$179.25M$0.00-$69.64M
2021-06-30(m)(m)$132.53M$169.67M$16.00K-$162.13M
2020-06-30(m)(m)$119.22M$152.65M$1.00K-$150.97M
2019-06-30(m)(m)$100.92M$143.43M$0.00-$140.59M
2018-06-30(m)(m)$61.85M$95.08M$3.00K-$92.33M
2017-06-30(m)(m)$35.84M$54.07M$2.00K-$53.08M
2016-06-30(m)(m)$24.24M$36.55M$3.00K-$35.44M
2015-06-30(m)(m)$17.27M$24.42M$2.00K-$24.11M
2014-06-30(m)(m)(m)$11.61M-$22.00K-$11.56M

Revenue and expense 9 month

Period endRevenueRevenue including taxResearch and developmentOperating expensesIncome taxNet income
2025-09-30$119.18M(m)$37.67M(m)$31.00K$36.09M
2024-09-30$96.19M$96.19M$122.76M(m)$7.00K-$72.71M
2023-09-30(m)$4.32M$175.19M(m)$4.00K-$215.68M
2022-09-30(m)$63.35M$210.02M$268.33M$10.00K-$153.73M
2021-09-30(m)(m)$202.87M$259.85M$16.00K-$246.79M
2020-09-30(m)(m)$179.10M$227.35M$7.00K-$225.31M
2019-09-30(m)(m)$154.46M$215.98M$0.00-$212.48M
2018-09-30(m)(m)$105.20M$155.29M$3.00K-$150.69M
2017-09-30(m)(m)$56.44M$85.73M$2.00K-$84.18M
2016-09-30(m)(m)$43.04M$62.49M$10.00K-$60.81M
2015-09-30(m)(m)$25.39M$36.68M-$9.00K-$35.97M
2014-09-30(m)(m)(m)$17.56M-$22.00K-$17.48M
2013-09-30(m)(m)(m)$5.20M$27.00K-$5.22M

Revenue and expense 12 month

Period endRevenueRevenue including taxResearch and developmentOperating expensesIncome taxNet income
2025-12-31$120.77M$120.77M$37.45M(m)$31.00K$32.69M
2024-12-31$128.94M$128.94M$151.48M(m)-$12.00K-$85.40M
2023-12-31$8.57M$8.57M$224.78M(m)$15.00K-$276.13M
2022-12-31(m)$63.57M$272.53M$344.09M$12.00K-$228.30M
2021-12-31(m)(m)$282.00M$360.80M$46.00K-$340.14M
2020-12-31(m)(m)$244.65M$309.05M$15.00K-$306.62M
2019-12-31(m)(m)$216.10M$295.68M$12.00K-$290.98M
2018-12-31(m)(m)$167.46M$237.11M-$44.00K-$230.70M
2017-12-31(m)(m)$81.21M$121.53M-$14.00K-$119.49M
2016-12-31(m)(m)$56.51M$81.24M$10.00K-$79.05M
2015-12-31(m)(m)$41.62M$58.45M-$9.00K-$57.22M
2014-12-31(m)(m)$15.45M$28.16M-$25.00K-$28.01M
2013-12-31(m)(m)(m)$8.62M$170.00K-$8.77M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
Vaxart, Inc. (VXRT)United States$0.080B3.84
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37